Chongqing Zhifei Biological Products Co., Ltd.: all 70 studies

Page 1 of 1. Open to participants first (8), then studies with results posted, then the rest; newest registration first within each.

• A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60Not yet recruitingNCT06970756Phase 1
• Clinical Trials of Quadrivalent Influenza VaccineRecruitingNCT06824519Phase 1/2
• Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old InfantsRecruitingNCT06344065Phase 3
• Safety, Tolerability, and Immunogenicity of Recombinant Meningococcal Group B Vaccine (E.Coli)RecruitingNCT06314880Phase 1
• Clinical Study of Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)Not yet recruitingNCT06025812Not applicable
• Consistency, Immunogenicity, and Safety of Three Batches of 15-valent Pneumococcal Conjugate VaccineRecruitingNCT05939219Not applicable
• Safety Study of COVID19 Vaccine on the MarketRecruitingNCT05890521Phase 4
• Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy VolunteersNot yet recruitingNCT04357522Phase 3
• Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02329730Phase 2Results posted
• Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT01999231Phase 1Results posted
• C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in IndonesiaCompletedNCT07587164Not applicable
• Phase II Clinical Clical of the Pure Protein Derivatives of BCGCompletedNCT06975774Phase 1
• Clinical Trial of the S. Flexneri-S. Sonnei Bivalent Conjugate VaccineActive, not recruitingNCT06838195Phase 3
• Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis VaccineCompletedNCT06817187Phase 3
• BCG for Therapeutic Use Phase Ⅲ Clinical TrialActive, not recruitingNCT06747455Phase 3
• Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate VaccineCompletedNCT06703203Phase 1/2
• Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)Active, not recruitingNCT06524947Phase 3
• Phase I Clinical Trial of Inactivated Rotavirus Vaccine in a Population Aged 6 Weeks-49 Years OldActive, not recruitingNCT06350058Phase 1
• Clinical Study on Lot-to-lot Consistency and Immune Persistence of Three Commercial Batches of PPSV23Active, not recruitingNCT06314867Phase 3
• Immunogenicity and Safety of MCV4 in Volunteers Aged 6 Months-5 YearsActive, not recruitingNCT06314685Phase 3
• Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 MonthsActive, not recruitingNCT06314659Phase 3
• BCG for Therapeutic Use Phase I Clinical TrialCompletedNCT06100653Phase 1
• A Clinical Trial of Freeze-dried Human Rabies Vaccine (MRC-5 Cells)CompletedNCT06078423Phase 3
• Omicron BA.4/5-Delta COVID-19 Vaccine Phase I Clinical TrialStatus unknownNCT06043388Phase 1
• Immunogenicity and Safety of Enterovirus Type 71 Vaccine,Inactivated(Vero Cells) in Volunteers Aged From 6 to 71 MonthsCompletedNCT05913024Phase 2
• Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and AboveCompletedNCT05899179Phase 3
• To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2CompletedNCT05895110Not applicable
• Omicron BA.4/5-Delta Strain Recombinant Novel Coronavirus Protein Vaccine (CHO Cells)CompletedNCT05850507Not applicable
• Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion ProteinCompletedNCT05746611Phase 4
• Clinical Trial of MicaActive, not recruitingNCT05680415Phase 4
• Phase Ⅲ Clinical Study of Quadrivalent Influenza Virus Split VaccineCompletedNCT05642078Phase 3
• A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)Status unknownNCT05616754Phase 3
• Recombinant Omicron-Delta COVID-19 Vaccine (CHO Cell)CompletedNCT05574985Not applicable
• A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)SuspendedNCT05284812Phase 2
• Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 5 MonthsStatus unknownNCT05252715Phase 3
• Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 MonthsCompletedNCT05229536Phase 2
• Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVacCompletedNCT05205096Phase 1/2
• Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of BBIBP-CorVStatus unknownNCT05205083Phase 1/2
• ZF2001 Booster Immunization Clinical Trials of 12 Months After the Completion of Basic ImmunizationCompletedNCT05198102Phase 1/2
• ZF2001 Booster Immunization Clinical Trials of 6 Months After the Completion of Basic ImmunizationCompletedNCT05198063Phase 1/2
• Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 YearsStatus unknownNCT05156528Phase 3
• Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Status unknownNCT05128643Phase 3
• Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)CompletedNCT05109598Phase 2
• Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza VaccineCompletedNCT05107375Phase 3
• Clinical Trials of the Consistency and Non-inferiority Bridging Between Batches of Recombinant New Coronavirus Vaccine (CHO Cells)Status unknownNCT05091411Phase 3
• Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing ImmunityCompletedNCT05089045Not applicable
• Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)CompletedNCT04961359Phase 1
• Immunogenicity and Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 3 Months to 5 Years OldCompletedNCT04865497Phase 2
• A Clinical Trial of Freeze-dried Human Rabies Vaccine (Vero Cells)Active, not recruitingNCT04852068Phase 3
• A Phase III Clinical Trial to Determine the Safety and Efficacy of ZF2001 for Prevention of COVID-19Status unknownNCT04646590Phase 3
• Phase I Clinical Protocol of BCG-PPD in Healthy PeopleCompletedNCT04593771Phase 1
• Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)CompletedNCT04563533Phase 1/2
• Clinical Study of BCG Vaccine for Intradermal InjectionCompletedNCT04563273Phase 1
• Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)Status unknownNCT04550351Phase 1
• Phase I Clinical Protocol for Pre-evaluation of the Safety of BCG-PPD in Tuberculosis PatientsActive, not recruitingNCT04538911Phase 1
• Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04466085Phase 2
• Phase I Clinical Study of Recombinant Novel Coronavirus VaccineStatus unknownNCT04445194Phase 1
• Immunogenicity and Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Healthy Volunteers Aged 2 Years and AboveCompletedNCT04278248Phase 3
• A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)CompletedNCT04239313Phase 1
• Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in Healthy Volunteers Aged Above 2 MonthsStatus unknownNCT04108845Phase 1
• Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsCompletedNCT03561181Phase 1
• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 Allergen for ChildrenCompletedNCT03027154Phase 3
• A Phase ⅠStudy of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-driedCompletedNCT03026972Phase 1
• Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of AgeStatus unknownNCT02919293Phase 1/2
• Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsStatus unknownNCT02878291Phase 1
• Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65(III-healthy)CompletedNCT02795260Phase 3
• Clinical Study of Recombinant Mycobacterium Tuberculosis ESAT6-CFP10 AllergenCompletedNCT02623556Phase 3
• Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65CompletedNCT02389322Phase 2
• Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT02336542Phase 2
• Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent TuberculosisCompletedNCT01979900Phase 3

← Chongqing Zhifei Biological Products Co., Ltd. overview and focus areas